Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: A systematic review of the literature

Journal of Rheumatology

Volumn 41, Issue SUPPL. 92, 2014, Pages 9-14

  Van Durme, Caroline ^a,b   Van Echteld, Irene A A M ^a,c   Falzon, Louise ^a,d   Aletaha, Daniel ^a,e   Van Der Heijde, Désirée M F M ^a,f   Landewé, Robert B ^a,g  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Rheumatology Department Centre Hospitalier Universitaire   (Netherlands)

^c CPRLab   (Netherlands)

^d NewYork Presbyterian Hospital   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g Academic Medical Center   (United States)

Author keywords

Cancer; Cardiovascular disease; Diabetes; Gout; Hypertension; Hyperuricemia; Renal insufficiency

Indexed keywords

CARDIOVASCULAR DISEASES; COMPLICATION; GOUT; HUMAN; HYPERURICEMIA; RISK FACTOR;

CARDIOVASCULAR DISEASES; GOUT; HUMANS; HYPERURICEMIA; RISK FACTORS;

EID: 84906888279     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140457     Document Type: Review

References (71)

1. Feig D, Kang D, Johnson R. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811-21.
2. Sivera F, Andrés M, Carmona L, Kydd AS, Moi J, Seth R, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 2014;73:328-35.
3. Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available from: www.cochrane-handbook.org
4. Hayden J, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427-37. (Pubitemid 46768164)
5. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523-30. (Pubitemid 36899556)
6. Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah: A screening analysis. Hypertension 1991;17:969-76.
7. Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y, et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Clin Exp Hypertens 2004;27:835-41. (Pubitemid 40309449)
8. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005;45:28-33. (Pubitemid 40066409)
9. Shankar A, Klein R, Klein BEK, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study. J Hum Hypertens 2006;20:937-45. (Pubitemid 44782827)
10. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, et al. Uric acid and the development of hypertension: The Normative Aging Study. Hypertension 2006;48:1031-6. (Pubitemid 44772704)
11. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, et al. Serum uric acid predicts incident hypertension in a biethnic cohort: The Atherosclerosis Risk in Communities Study. Hypertension 2006;48:1037-42. (Pubitemid 44772705)
12. Zhang W, Sun K, Yang Y, Zhang H, Hu FB, Hui R. Plasma uric acid and hypertension in a Chinese community: Prospective study and metaanalysis. Clin Chem 2009;55:2026-34.
13. Zhang H, Li Y, Tao S, Zhou B, Folsom AR, Irving S, et al. Relationship of serum uric acid to 4-year incidence of hypertension and blood pressure change in a Chinese population. CVD Prevention 2000;3:221-8. (Pubitemid 32427681)
14. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, et al. Serum uric acid and hypertension: The Olivetti Heart Study. J Hum Hypertens 1994;8:677-81. (Pubitemid 24276965)
15. Dyer AR, Liu K, Walsh M, Kiefe C, Jacobs DR Jr, Bild DE. Ten-year incidence of elevated blood pressure and its predictors: The CARDIA Study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens 1999;13:13-21. (Pubitemid 29042140)
16. Imazu M, Yamamoto H, Toyofuku M, Sumii K, Okubo M, Egusa G, et al. Hyperinsulinemia for the development of hypertension: Data from the Hawaii-Los Angeles-Hiroshima Study. Hypertens Res 2001;24:531-6. (Pubitemid 33048919)
17. Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007;49:298-303. (Pubitemid 46143005)
18. Kahn HA, Medalie JH, Neufeld H, Riss E, Goldbourt U. The incidence of hypertension and associated factors: The Israel Ischemic Heart Disease Study. Am Heart J 1972;84:171-82.
19. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens 2001;19:1209-15. (Pubitemid 32595276)
20. Wang T, Bi Y, Xu M, Huang Y, Xu Y, Li X, et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 2011;40:109-16.
21. Bhole V, Choi JWJ, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: A prospective study. Am J Med 2010;123:957-61.
22. Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H. Sex differences in risk factors for incident type 2 diabetes mellitus: The MONICA Augsburg Cohort Study. Arch Intern Med 2002;162:82-9. (Pubitemid 34073405)
23. Dehghan A, van Hoek M, Sijbrands EJG, Hofman A, Witteman JCM. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361-2. (Pubitemid 351213351)
24. Lin KC, Tsai ST, Lin HY, Chou P. Different progression of hyperglycemia and diabetes among hyperuricemic men and women in the Kinmen Study. J Rheumatol 2004;31:1159-65. (Pubitemid 38715893)
25. Kramer CK, von Muhlen D, Jassal SK, Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: The Rancho Bernardo Study. Diabetes Care 2009;32:1272-3.
26. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009;266:558-70.
27. Goldberg RJ, Burchfiel CM, Benfante R, Chiu D, Reed DM, Yano K. Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men: 20-Year findings from the Honolulu Heart Program. Arch Intern Med 1995;155:686-94.
28. Chien K-L, Hsu H-C, Sung F-C, Su T-C, Chen M-F, Lee Y-T. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2005;183:147-55. (Pubitemid 41416833)
29. Jee SH, Lee SY, Kim MT. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Prev Cardiol 2004;11:185-91. (Pubitemid 38870064)
30. Gerber Y, Tanne D, Medalie JH, Goldbourt U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Prev Cardiol 2006;13:193-8. (Pubitemid 44097723)
31. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke. The Rotterdam Study. Stroke 2006;37:1503-7. (Pubitemid 44305733)
32. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: A prospective long-term study of 83,683 Austrian men. Clin Chem 2008;54:273-84. (Pubitemid 351302628)
33. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study. Int J Cardiol 2008;125:232-9.
34. Persky VW, Dyer AR, Idris-Soven E, Stamler J, Shekelle RB, Schoenberger JA, et al. Uric acid: A risk factor for coronary heart disease? Circulation 1979;59:969-77. (Pubitemid 9163955)
35. Chen JH, Chuang SY, Chen HJ, Wen-Ting YEH, Wen-Harn PAN. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study. Arthritis Care Res 2009;61:225-32.
36. Takagi M. Serum uric acid as a risk factor for stroke in a fishing village of rural Southern Japan. Jpn Circ J 1982;46:131-6. (Pubitemid 12148398)
37. Hozawa A, Folsom AR, Ibrahim H, Javier Nieto F, Rosamond WD, Shahar E. Serum uric acid and risk of ischemic stroke: The ARIC Study. Atherosclerosis 2006;187:401-7. (Pubitemid 43963022)
38. Mazza A, Pessina AC, Pavei A, Scarpa R, Tikhonoff V, Casiglia E. Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol 2001;17:1097-104.
39. Sakata K, Hashimoto T, Ueshima H, Okayama A, Group NDR. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged. Eur J Epidemiol 2001;17:461-8. (Pubitemid 34105990)
40. Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matuoka Y, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 2000;10:403-9.
41. Teng GG, Ang LW, Saag KG, Yu MC, Yuan JM, Koh WP. Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Ann Rheum Dis 2012;71:924-8.
42. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 1999;131:7-13. (Pubitemid 29310011)
43. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000;10:136-43. (Pubitemid 30171270)
44. Meisinger C, Koenig W, Baumert J, Doring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: The MONICA/KORA Cohort Study. Arterioscler Thromb Vasc Biol 2008;28:1186-92.
45. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992. JAMA 2000;283:2404-10. (Pubitemid 30257539)
46. Aboa Eboule AC, De Smet P, Dramaix M, De Backer G, Kornitzer M. [Relation between uricemia and total, cardiovascular and coronary mortality in both genders of non-selected sample of the Belgium population]. Rev Epidemiol Sante Publique 2001;49:531-9.
47. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: Findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989;42:257-67. (Pubitemid 19117031)
48. Puddu PE, Lanti M, Menotti A, Mancini M, Zanchetti A, Cirillo M, et al. Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population study. Acta Cardiol 2001;56:243-51. (Pubitemid 32848607)
49. Baibas N, Trichopoulou A, Voridis E, Trichopoulos D. Residence in mountainous compared with lowland areas in relation to total and coronary mortality. A study in rural Greece. J Epidemiol Community Health 2005;59:274-8. (Pubitemid 40460578)
50. Lin K-C, Tsao H-M, Chen C-H, Chou P. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia. J Rheumatol 2004;31:1152-8. (Pubitemid 38715892)
51. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995;141:637-44.
52. Strasak AM, Rapp K, Hilbe W, Oberaigner W, Ruttmann E, Concin H, et al. The role of serum uric acid as an antioxidant protecting against cancer: Prospective study in more than 28 000 older Austrian women. Ann Oncol 2007;18:1893-7.
53. Krishnan E, Baker J, Furst D, Schumacher H. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688-96. (Pubitemid 44208638)
54. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116:894-900. (Pubitemid 47300913)
55. De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. Independent impact of gout on the risk of acute myocardial infarction among elderly women: A population-based study. Ann Rheum Dis 2010;69:1162-4.
56. Kuo CF, Yu KH, See LC, Chou IJ, Ko YS, Chang HC, et al. Risk of myocardial infarction among patients with gout: A nationwide population-based study. Rheumatology 2013;52:111-7.
57. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH; MRFIT Research Group. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008;168:1104-10. (Pubitemid 351749228)
58. Gelber AC, Klag MJ, Mead LA, Thomas J, Thomas DJ, Pearson TA, et al. Gout and risk for subsequent coronary heart disease: The Meharry-Hopkins study. Arch Intern Med 1997;157:1436-40. (Pubitemid 27300389)
59. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: The Framingham Study. J Clin Epidemiol 1988;41:237-42. (Pubitemid 18069583)
60. Baker JF, Schumacher HR, Krishnan E. Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the Multiple Risk Factor Intervention Trial. Angiology 2007;58:450-7. (Pubitemid 47301052)
61. Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Res 1988;48:2916-18.
62. Kolonel LN, Yoshizawa C, Nomura AM, Stemmermann GN. Relationship of serum uric acid to cancer occurrence in a prospective male cohort. Cancer Epidemiol Biomarkers Prev 1994;3:225-8. (Pubitemid 24172535)
63. Strasak AM, Rapp K, Hilbe W, Oberaigner W, Ruttmann E, Concin H, et al. Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control 2007;18:1021-9. (Pubitemid 47237964)
64. Kuo CF, Luo SF, See LC, Chou IJ, Fang YF, Yu KH. Increased risks of cancer among gout patients: A nationwide population study. Joint Bone Spine 2012;79:375-8.
65. Hsu C-y, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009;169:342-50.
66. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44:642-50. (Pubitemid 39237608)
67. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: A systematic review and meta-analysis. Arthritis Care Res 2011;63:102-10.
68. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009;32:1737-42.
69. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: A systematic review and meta-analysis. Arthritis Care Res 2010;62:170-80.
70. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: A systematic review and meta-analysis. Arthritis Rheum 2009;61:885-92.
71. Wheeler JG, Juzwishin KDM, Eiriksdottir G, Gudnason V, Danesh J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: Prospective study and meta-analysis. PLoS Med 2005;2:e76.